戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  patients, TAVI was performed without aortic balloon valvuloplasty.
2 g transcatheter aortic valve implantation or balloon valvuloplasty.
3 e for infants and neonates is trans-catheter balloon valvuloplasty.
4 sis before and 20 to 30 min after undergoing balloon valvuloplasty.
5 do-TAVI, 79 (39%) plug closure, and 35 (18%) balloon valvuloplasty.
6 ial results are obtained with trans-catheter balloon valvuloplasty, although stenosis resistant to fu
7 agnostic and therapeutic purposes, including balloon valvuloplasties and electrophysiologic ablation
8 and safety of established procedures such as balloon valvuloplasty and coarctation angioplasty.
9 que, and long-term studies of trans-catheter balloon valvuloplasty and surgical valvotomy warrant a r
10 e analysis, having the relief of stenosis by balloon valvuloplasty and undergoing initial treatment a
11 s), having a surgical AV procedure or aortic balloon valvuloplasty at Children's Hospital of Oklahoma
12 promising mid-term and long-term results for balloon valvuloplasty, balloon atrial septostomy and pul
13 lic murmur at 16 months of age and underwent balloon valvuloplasty for severe valvular aortic stenosi
14                                Transcatheter balloon valvuloplasty for the treatment of aortic and pu
15 tructures in patients with critical PS after balloon valvuloplasty has not clearly been defined.
16                                        Fetal balloon valvuloplasty has shown promise.
17                   New advances such as fetal balloon valvuloplasty, improvements in the Ross techniqu
18 eased when cardiac output was improved after balloon valvuloplasty in patients with aortic stenosis.
19                  While availability of fetal balloon valvuloplasty is limited, it has promise for pro
20                                 Percutaneous balloon valvuloplasty is the treatment of choice for pat
21 e of severe aortic and pulmonary stenoses by balloon valvuloplasty may diminish their postnatal expre
22 theterization techniques were pioneered with balloon valvuloplasty of pulmonic stenosis in infants.
23  0.004) and a greater number of aortic valve balloon valvuloplasties (p = 0.003).
24                    By multivariate analysis, balloon valvuloplasty (p < 0.001) and treatment as a neo
25 tation patients with aortic regurgitation or balloon valvuloplasty patients (no correction).
26 g-term outcome of repeat percutaneous mitral balloon valvuloplasty (PMV) for post-PMV mitral restenos
27                          Percutaneous mitral balloon valvuloplasty (PMV) results in good immediate re
28 e of patients undergoing percutaneous mitral balloon valvuloplasty (PMV).
29        The NHLBI established the multicenter Balloon Valvuloplasty Registry in November 1987 to asses
30 nal Heart, Lung, and Blood Institute (NHLBI) Balloon Valvuloplasty Registry.
31 es with surgery; the benefit of percutaneous balloon valvuloplasty to mortality might be similar to t
32 rom re-intervention at 5 years was 27% after balloon valvuloplasty versus 65% after surgery.